GH: Guardant Health, Inc. Stock

by  •  • Comments Off on GH: Guardant Health, Inc. Stock

SIC 8071 – Medical Laboratories

Valuation
Market Cap ($M) 5,324.40
Enterprise Value ($M) 5,941.41
Book Value ($M) -139.65
Book Value / Share -1.13
Price / Book -38.13
NCAV ($M) -570.14
NCAV / Share -4.62
Price / NCAV -9.34

Profitability (mra)
Return on Invested Capital (ROIC) -0.36
Return on Assets (ROA) -0.26
Return on Equity (ROE) -6.39

Liquidity (mrq)
Quick Ratio 4.36
Current Ratio 4.68

Balance Sheet (mrq) ($M)
Current Assets 1,055.11
Assets 1,485.61
Liabilities 1,625.26
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 739.02
Operating Income -443.59
Net Income -436.37
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -239.86
Cash from Investing -261.31
Cash from Financing -1.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Cadian Capital Management, Lp 4.20 -25.49
02-10 13G/A Wellington Management Group Llp 3.90 -52.11
10-07 13G Deep Track Capital, LP 5.35 -6.00
07-05 13G/A Baillie Gifford & Co 4.98 -1.38

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-31 374,839 1,166,503 32.13
2025-03-28 229,095 908,151 25.23
2025-03-27 272,735 985,392 27.68

(click for more detail)

Similar Companies
FTRE – Fortrea Holdings Inc. NTRA – Natera, Inc.


Financial data and stock pages provided by
Fintel.io